Submission Information

  • This web site is for initial submission of Investigator-Initiated Studies (IIS) only.
  • We will consider any study that involves XARELTO® (rivaroxaban) or INVOKANA (canagliflozin) that addresses clinically relevant questions regarding the use of our drugs.
  • If you would like to discuss your concept or submission requirements/forms prior to submitting your proposal, click Contact Us and your local MSL will contact you.
  • You may download the required forms by clicking on Forms
  • A Janssen Scientific Affairs Medical and Science Liaison (MSL) will contact you within 3 days of your complete concept submission.
  • The concept approval process is a multi-step approach. The local MSL will communicate with you regularly as the process advances.

Required information for concept submission:

The Clinical or Non-Clinical IIS Research Support Application is a template for you to submit information regarding you and your site, study proposal and budget. You will need to complete, sign and fax/email this form to Janssen Scientific Affairs, LLC before any concept will be evaluated.For additional details regarding the IIS review process click on the link below.

Overview of IIS Review Process Document.

Requirements for concept submission:

  1. Download the Clinical (IIS) Research Support Application or Non-Clinical (IIS) Research Support Application.
  2. Complete all pages of the Clinical (IIS) Research Support Application or Non-Clinical (IIS) Research Support Application sign, date and email copy via the Submit Concept tab.
    • Please retain the original copy for collection at a later date and make a copy for your files
  3. Submit your Current Curriculum Vitae (CV).
  4. Provide current Contact Information.